South Texas Accelerated Research Therapeutics (START) San Antonio — San Antonio, Texas

South Texas Accelerated Research Therapeutics (START) San Antonio is a clinical research site located in San Antonio, Texas, United States 78229.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

South Texas Accelerated Research Therapeutics (START) San Antonio has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC), CCNE1 Amplified Advanced Solid Tumors.

Sponsors: NiKang Therapeutics, Inc., Sensei Biotherapeutics, Inc., MacroGenics.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for South Texas Accelerated Research Therapeutics (START) San Antonio?

South Texas Accelerated Research Therapeutics (START) San Antonio has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has South Texas Accelerated Research Therapeutics (START) San Antonio conducted?

South Texas Accelerated Research Therapeutics (START) San Antonio has 3 clinical trials on record, with 3 currently active. Their work covers HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC), CCNE1 Amplified Advanced Solid Tumors.

Is South Texas Accelerated Research Therapeutics (START) San Antonio accredited by Crixeo Health?

South Texas Accelerated Research Therapeutics (START) San Antonio has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about South Texas Accelerated Research Therapeutics (START) San Antonio?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.